The influence of HAART therapy on bone loss in HIV-infected patients

被引：0
|
作者：
Boccassini, L
Antivalle, M
Santalena, G
Santandrea, S
Sarzi-Puttin, P
Vulpio, L
Landonio, S
Gabris, A
Marrazza, M
Randis, G
Carrabba, M
机构：
[1] L Sacco Univ Hosp, Milan, Italy
[2] Osped L Sacco, Milan, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2003年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：508 / 509
页数：2
相关论文
共 50 条
  • [41] Prevalence of cryptococcal subclinical infection in HIV-infected patients initiating HAART
    Rodriguez, V.
    Klajn, D.
    Molina, A. M.
    Cagnoni, A.
    Russo Lacerna, D.
    Bustamante, J. C.
    Zalazar, N.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 235 - 235
  • [42] Nonorgan-specific autoantibodies in HIV-infected patients in the HAART era
    Iordache, Laura
    Bengoufa, Djaouida
    Taulera, Olivier
    Rami, Agathe
    Lascoux-Combe, Caroline
    Day, Nesrine
    Parrinello, Maguy
    Sellier, Pierre-Olivier
    Molina, Jean-Michel
    Mahr, Alfred
    MEDICINE, 2017, 96 (10)
  • [43] Opportunistic events shortly after beginning HAART in HIV-infected patients
    González-Castillo, J
    Blanco, F
    Soriano, V
    Barreiro, P
    Bravo, MC
    Jiménez-Nácher, I
    González-Lahoz, J
    MEDICINA CLINICA, 2001, 117 (03): : 81 - 84
  • [44] Lipodystrophy Syndrome by HAART in HIV-Infected Patients: Manifestation, Mechanisms and Management
    H. H. Hirsch
    M. Battegay
    Infection, 2002, 30 : 293 - 298
  • [45] Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART
    Calza, L
    Manfredi, R
    Chiodo, F
    AIDS, 2003, 17 (06) : 851 - 859
  • [46] Therapeutic drug monitoring of indinavir in HIV-Infected patients undergoing HAART
    Langmann, R
    Zilly, M
    Weissbrich, B
    Desch, S
    Väth, T
    Klinker, H
    INFECTION, 2002, 30 (01) : 13 - 16
  • [47] Lipodystrophy syndrome by HAART in HIV-Infected patients: Manifestation, mechanisms and management
    Hirsch, HH
    Battegay, M
    INFECTION, 2002, 30 (05) : 293 - 298
  • [48] Seven years of HAART impact on ophthalmic management of HIV-infected patients
    Kahraman, G
    Krepler, K
    Franz, C
    Ries, E
    Maar, N
    Wedrich, A
    Rieger, A
    Dejaco-Ruhswurm, I
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2005, 13 (2-3) : 213 - 218
  • [49] Body composition studies in HIV-infected subjects with ≥10% weight loss in the pre-HAART and HAART eras
    Nathan, N
    Engelson, ES
    Simons, G
    Muurahainen, N
    Gertner, J
    Kotler, DP
    FASEB JOURNAL, 2004, 18 (04): : A548 - A548
  • [50] Sexual risk behaviour and HAART: a comparative study of HIV-infected persons on HAART and on preventive therapy in Kenya
    Sarna, A.
    Luchters, S. M. F.
    Geibel, S.
    Kaai, S.
    Munyao, P.
    Shikely, K. S.
    Mandaliya, K.
    van Dam, J.
    Temmerman, M.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2008, 19 (02) : 85 - 89
12345